Drostanolone (Masterone) is medically prescribed as an anti-estrogenic therapy for the treatment of advanced inoperable breast cancer in postmenopausal women. It was originally manufactured under pharmaceutical production by Lilly/Syntex during the 1970s. The drug is an injectable AAS derived from dihydrotestosterone (DHT). It
DROSTANOLONE









